WHO official thinks the COVID-19 vaccine booster debate is all wrong


The World Health Organization's director of immunization, vaccination, and biologics argues it may be too early to push for population-level COVID-19 booster shots, especially when many people around the world have not even received their first dose.
There just isn't enough evidence right now to back up the need for widespread boosters in heavily vaccinated countries, director Kate O'Brien suggested in an interview with Stat News. Looking specifically at the two-dose mRNA vaccines produced by Pfizer and Moderna, O'Brien said the timing and rationale for third doses isn't really about "boosting," anyway. Instead, "it's actually about whether ... you need a third priming dose" for people who are immunocompromised. "For some vaccines ... there seems to be evidence coming forward, more about people who are having a failure of the primary series [of shots] and evidence on whether or not a third priming dose would help," she said.
With that in mind, a "much more important message" than whether all fully immunized folks need to get a booster is that "we have really have huge inequity right now in just getting primary doses to people," O'Brien continued.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"The focus [of Covid vaccination] really is on reducing serious disease, hospitalizations, and death," she said. "And when you look at the deployment of the vaccines globally, a whole lot of those vaccines have gone to people who have extremely low risk of that happening, while at the same time there are huge numbers of people who do fall into that risk group who haven't been vaccinated. We're just really out of kilter here." Read O'Briens full interview at Stat News.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Israel Defense Forces' manpower problem
The Explainer Israeli military's shortage of up to 12,000 troops results in call-up for tens of thousands of reservists
-
Quiz of The Week: 16 – 22 August
Quiz Have you been paying attention to The Week's news?
-
Can Soho House get its edge back?
Talking Point The private members' club has lost its exclusive appeal – but a £2 billion buy-out could offer a fresh start
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Cytomegalovirus can cause permanent birth defects
The Explainer The virus can show no symptoms in adults
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots